Yuri Asami
Overview
Explore the profile of Yuri Asami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanzaki K, Nakagomi Y, Asami Y, Honma H, Yokoyama Y, Seki H, et al.
J Am Chem Soc
. 2025 Mar;
PMID: 40083051
Glycoproteins are often considered as drug candidates. However, the regulation of post-translational glycan attachment remains an issue. We hypothesized that replacing the oxygen atom in the glycosidic linkage with sulfur...
2.
Otonari K, Asami Y, Ogata K, Ishihama Y, Futaki S, Imanishi M
Chem Commun (Camb)
. 2024 Nov;
61(1):69-72.
PMID: 39499124
Recent advancements in tools using programmable RNA binding proteins and mA-erasers enable sequence-selective and timing-controllable mA demethylation. However, off-target effects are still a concern. This study addresses the problem by...
3.
Umeda Y, Teramoto Y, Asami Y, Matsuya T, Saito S, Sasaki K, et al.
J Dermatol
. 2022 Jun;
49(10):1020-1026.
PMID: 35758239
Skin cancer patients with clinical nodal disease or whose positive sentinel nodes had great tumor burden remain candidates for regional lymph node dissections. Among these patients, inguinal or ilioinguinal lymph...
4.
Matsuya T, Nakamura Y, Matsushita S, Tanaka R, Teramoto Y, Asami Y, et al.
J Dermatol
. 2020 Apr;
47(6):629-635.
PMID: 32275100
Vitiligo is an autoimmune disorder resulting from the destruction of melanocytes. Several reports indicate the association between vitiligo and treatment response in advanced melanoma during immunotherapy. It has not been...
5.
Sasaki K, Nakamura Y, Baba N, Teramoto Y, Asami Y, Kaira K, et al.
J Dermatol
. 2020 Mar;
47(5):e188-e190.
PMID: 32141093
No abstract available.
6.
Asami Y, Kawaguchi Y, Kanie Y, Abdu-Allah H, Suzuki K, Kanie O
Carbohydr Res
. 2019 Feb;
474:51-56.
PMID: 30731331
Trimethylsilylation of the anomeric hydroxyl groups of tetra-O-benzyl and tetra-O-acetyl galactopyranoses was investigated. Stereoselective formation of β-trimethylsilyl glycoside (β-TMS glycoside) of benzyl protected compound was achieved using N-trimethylsilyl diethylamine. In...
7.
Yano M, Asami Y, Nishikawa T, Yoshida S, Kamada K, Katoh T, et al.
Medicine (Baltimore)
. 2018 Nov;
97(43):e12937.
PMID: 30412106
Rationale: Malignant melanoma (MM) arising in ovarian cystic teratoma (OCT) is a rare disease with poor prognosis. Recently, immune checkpoint inhibitors of cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) and programmed death...
8.
Teramoto Y, Nakamura Y, Asami Y, Matsuya T, Brinker T, Jansen P, et al.
Eur J Dermatol
. 2018 Aug;
28(4):532-534.
PMID: 30129521
No abstract available.
9.
Asami Y, Nakamura Y, Teramoto Y, Sato S, Matsuya T, Yamamoto A
J Dtsch Dermatol Ges
. 2018 Mar;
16(3):350-352.
PMID: 29537162
No abstract available.
10.
Asami Y, Nakamura Y, Teramoto Y, Sato S, Matsuya T, Yamamoto A
J Dtsch Dermatol Ges
. 2018 Feb;
16(3):350-352.
PMID: 29431902
No abstract available.